Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring

NCT00707512 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT00707512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00707512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Lead sponsor
Biogen
Phase
Observational
Overall status
Terminated
Start date
June 30, 2008
Completion date
May 28, 2015
Enrollment
87 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease